SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-144139
Filing Date
2020-05-15
Accepted
2020-05-15 17:07:56
Documents
3
Period of Report
2020-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d900736d8k.htm 8-K 21508
2 EX-10.1 d900736dex101.htm EX-10.1 69353
3 GRAPHIC g900736g81x69.jpg GRAPHIC 2085
  Complete submission text file 0001193125-20-144139.txt   95081
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 20886669
SIC: 2834 Pharmaceutical Preparations